Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Blue Water Ventures International Inc (OP: BWVI )

0.0001 UNCHANGED
Last Price Updated: 2:24 PM EDT, Oct 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Blue Water Ventures International Inc

< Previous 1 2 Next >
Novel Ketamine Topical Cream To Treat PTSD Gets First In-Human Trials
Psycheceutical Bioscience (OTCPK: BWVI) is advancing its proprietary ketamine topical formulation into clinical studies. The life sciences company has partnered with Australian-based contract research... 
Via Benzinga
Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD
From Psycheceutical Bioscience, Inc.
Via GlobeNewswire
Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD
Company intends to pursue 505(b)(2) regulatory pathway for novel topical formulation of ketamine for the treatment of PTSD 
From Psycheceutical Bioscience, Inc.
Via GlobeNewswire
Zappy Zapolin's Psycheceutical Files Patent, Hopes Ketamine Topical Can Treat PTSD
Lifesciences biotech company Psycheceutical Bioscience (OTC: BWVI), of which Benzinga’s advisory council member Zappy Zapolin is Chief Vi 
Via Benzinga
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD
Topical ketamine formulations could improve the methods of treating post-traumatic stress disorder (PTSD) 
From Psycheceutical Bioscience, Inc.
Via GlobeNewswire
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer
Renowned neurosurgeon to oversee the development of breakthrough psychedelic therapeutics 
From Psycheceutical Bioscience, Inc.
Via GlobeNewswire
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director
Dr. Logsdon’s expertise to help guide the company’s further research and development for its patented drug-delivery technology 
From Psycheceutical Bioscience, Inc.
Via GlobeNewswire
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board
To be led by accomplished Neurosurgeon Dr. Julian Bailes, the Medical Advisory Board will support the Company in developing breakthrough psychedelic medicine technologies for mental health treatments 
From Psycheceutical Bioscience, Inc.
Via GlobeNewswire
Zappy Zapolin Of Psycheceutical Bioscience Joins The Benzinga Psychedelics Advisory Council: What You Need To Know
Zappy Zapolin, Chief Visionary Officer at Psycheceutical Bioscience, Inc. 
Via Benzinga
Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council
Chief Visionary Officer of Psycheceutical, Zappy Zapolin, will join other prominent leaders in Psychedelics on Benzinga’s Council Board 
From Psycheceutical Bioscience, Inc.
Via GlobeNewswire
Psychedelic Acquisition: Psycheceutical To Buy Majority Equity Stake In Maryland R&D Company
Publicly traded psychedelics company Psycheceutical Bioscience Inc. (OTC: BWVI) is signing an exclusive purchase option with end-to-end pharma R&D company Vici Health Sciences’ majority equity stake. 
Via Benzinga
EXCLUSIVE: Kevin Harrington Becomes The Latest 'Shark Tank' Judge To Enter The Psychedelics Space
The psychedelics industry is quickly becoming the latest playground for celebrity investors and influencers in the financial sphere. Kevin Harrington, one of the original “sharks” in ABC's “Shark Tank”... 
Via Benzinga
Researcher Portrayed In Hollywood Movie By Alec Baldwin Joins Psychedelics Company
In 2015, the movie ​​Concussion, starring Will Smith and Alec Baldwin, told the true story of a doctor and his fight against the National Football League to... 
Via Benzinga
Psycheceutical Completes Acquisition by Blue Water Ventures International
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Blue Water Ventures International, Inc. Signs Non-Binding Letter of Intent to Acquire Psycheceutical, Inc.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Blue Water Ventures International and Partners Endurance Exploration Group Share Update on the Current 2021 Recovery Season of Steamboat Pulaski
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
New Sonar Survey Discovers Large Unsalvaged Sections of SB Pulaski, 1838
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.